Physician profile
Dennis M Killian
NPI 1568411536
$459.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $38.60 · 2021: $156 · 2022: $44.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $91.53 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $74.36 | 2019-2021 | |
| Pfizer INC. | $67.47 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $38.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.02 | 2019-2020 | |
| Chiesi USA, INC. | $25.88 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.45 | 2019-2021 | |
| Novo Nordisk INC | $24.96 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $22.11 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $15.83 | 2021 | |
| Amgen INC. | $14.07 | 2019 | |
| Allergan, INC. | $12.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.13 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Killian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.